Skip to content

Dortmund, 1st April 2022

Bei Kaja Reifferts Forschung spielen Bakterien wie Escherichia coli (E. coli) eine wichtige Rolle. Die Nachwuchswissenschaftlerin beobachtet unter anderem die Entwicklung der von ihr kultivierten und behandelten Bakterienstämme.
© ISAS

Bacteria such as Escherichia coli (E. coli) play an important role in Kaja Reiffert’s research. The young scientist monitors the development of the bacterial strains she has cultivated and treated.

Kaja Reiffert (24) is a doctoral student in the Bioimaging working group. In her dissertation, she studies the effects of ultra-small silver nanoparticles on the human body. In order to learn more about her work in the lab, the editorial team asked Kaja to finish the following sentences.

  • At ISAS I am working on…

    investigating the influence of ultra-small metallic nanoparticles (1-2 nm small) on eukaryotic and prokaryotic cells. Eurkaryotes are, for example, fungi, animals or plants. Bacteria are prokaryotes.

  • This research question is important because…

    nanoparticles could potentially prevent bacterial infection in connection with implants in the clinic.

  • My theory is…

    that ultra-small silver nanoparticles show an enhanced antimicrobial effect, but also cytotoxic activity. This means there is a chance that they kill bacteria, but damage our cells at the same time. I want to find out whether I can modulate this ‘toxic’ activity through a combination of different metals and thus adjust it to eukaryotic and prokaryotic cells.

  • The equipment I use most in the lab is…

    the confocal microscope for my analysis of fluorescence-marked nanoparticles.

  • My experiments are…

    amongst others, so-called vitality assays, the cultivation of eukaryotic and prokaryotic cells as well as analyses with microscopes and a flow cytometer. I am always planning new experiments.

  • My highlight every day is…

    to be able to look back on a productive and eventful day.

Kaja Reiffert is doing her PhD at the University of Duisburg-Essen. The title of her dissertation is "Ultra-small Mono- and Bi-metallic Nanoparticles as a Possible Prevention Strategy of Implant-associated Infections" (Ultrakleine mono- und bimetallische Nanopartikel als mögliche Präventionsstrategie Implantat-assoziierter Infektionen). Her work contributes to the research project "Synthesis, structure, and biological effects of ultrasmall (1-2 nm) bimetallic silver-platinum nanoparticles". The German Research Association (DFG) funds the project under the number 452179459.

Share

Further articles

Copenhagen: Different Molecules, New Perspectives?

Felix Hormann is spending three months conducting research at the University of Copenhagen. In this interview, the ISAS doctoral student discusses the new perspective he has gained on his lipid research and his exciting day-to-day life as a scientist in Denmark.

Felix Hormann is standing at a crossroads. In the background, there is a traffic sign with writing in Danish.

New Perspectives for Heart Failure Therapy

How are new therapeutic approaches being developed to close the gap in the treatment of patients with heart failure? And what knowledge from clinical practice is crucial for this? Prof. Dr Tanja Rudolph provides insights into her daily work as a cardiologist and talks about her role in the translational research project HI-FIVE, and the future of cardiovascular disease therapy.

PODCAST »NACHGEFORSCHT – DIE LIVESCHALTE INS LABOR« Episode 12: Less Is More, at Least When It Comes to the Number of Cells

PhD student Susmita Ghosh talks about her research on neutrophil granulocytes – tiny immune cells that play a role in both defending the body against infections and inflammatory processes. Instead of working with countless cells, the biologist optimises analytical methods to enable meaningful proteome analyses with an extremely small number of cells. Ghosh explains why ‘less is more’ and what this has to do with modern mass spectrometry in episode 12 of the podcast.

What are you doing at ISAS, Nora?

Nora Pauly is writing her doctoral thesis on the consequences of heart attacks at the joint graduate college of Essen University Hospital and ISAS. With the bed-to-bench-to-bed principle, her work in basic research is closely linked to the everyday clinical practice of caring for heart attack patients.

New Framework for Efficient Image Data Analysis in Biomedicine

How can AI be used optimally in bioimaging research? A team of international researchers and scientists led by Dr Jianxu Chen from ISAS has developed a framework designed to make it easier for biomedical scientists to work with data-centric AI. Using the example of vascular segmentation, the authors of the publication in the journal npj imaging now demonstrate the advantages of the new framework.

3 Questions for Susmita Ghosh

How does gut microbiota affect the immune system? Susmita Ghosh conducts research on proteins and immune cells at ISAS. In this interview, the biologist talks about her work and explains how gut flora and the immune system could affect the outcomes of a stroke.

Susmita Ghosh sitzt am ultrasensitiven Massenspektrometer und stellt eine Proben ein.

Gut Flora & Stroke: How Microorganisms Influence Our Immune System

Which factors can activate immune cells after a stroke? This question was investigated by researchers at University Hospital Essen and ISAS. Their work focused on the gut microbiota.

3 Questions for Dr Ali Ata Tuz

In his doctorate, Dr Ali Ata Tuz researched the causes of immunodeficiency after strokes and was already working closely with ISAS at the time. Following this, he subsequently devoted himself to the behaviour of immune cells in the bioimaging research group at ISAS. In this interview, the physician talks about his path from the clinic to application-oriented basic research.

Dr. Ali Ata Tuz sitzt am Konfokalmikroskop und schaut frontal in die Kamera.. Auf dem Bildschirm nebem dem Mirkoskop sind in grün und violett Mikroskopaufnahmen von einer Probe im Mikroskop zu sehen.

Heart Failure Rarely Occurs on Its Own: ISAS Researchers Develop New Treatment Pillars

The symptoms, subsequent problems and therapeutic challenges of patients with heart failure are increasingly challenging for general practitioners and cardiologists. Doctors are limited in their choice of treatment options, especially for patients with additional diseases. At ISAS, researchers are therefore focussing on broadening the therapeutic spectrum.

Prof. Dr. Kristina Lorenz.